nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2C8—Fluorouracil—head and neck cancer	0.1	0.284	CbGbCtD
Ketamine—CYP2C9—Fluorouracil—head and neck cancer	0.0699	0.198	CbGbCtD
Ketamine—ABCB1—Vinblastine—head and neck cancer	0.0628	0.178	CbGbCtD
Ketamine—ABCB1—Docetaxel—head and neck cancer	0.0518	0.147	CbGbCtD
Ketamine—TACR1—trigeminal nerve—head and neck cancer	0.0435	0.289	CbGeAlD
Ketamine—CYP3A4—Vinblastine—head and neck cancer	0.0376	0.107	CbGbCtD
Ketamine—CYP3A4—Docetaxel—head and neck cancer	0.031	0.0878	CbGbCtD
Ketamine—TACR1—cranial nerve—head and neck cancer	0.031	0.206	CbGeAlD
Ketamine—TACR1—connective tissue—head and neck cancer	0.0064	0.0426	CbGeAlD
Ketamine—GRIN2C—thyroid gland—head and neck cancer	0.00561	0.0373	CbGeAlD
Ketamine—TACR1—trachea—head and neck cancer	0.00537	0.0357	CbGeAlD
Ketamine—GRIN2C—head—head and neck cancer	0.00498	0.0331	CbGeAlD
Ketamine—GRIN2D—head—head and neck cancer	0.00463	0.0308	CbGeAlD
Ketamine—GRIN3A—head—head and neck cancer	0.00435	0.0289	CbGeAlD
Ketamine—GRIN1—head—head and neck cancer	0.00412	0.0274	CbGeAlD
Ketamine—GRIN2B—head—head and neck cancer	0.00393	0.0262	CbGeAlD
Ketamine—TACR1—head—head and neck cancer	0.00377	0.0251	CbGeAlD
Ketamine—GRIN2A—head—head and neck cancer	0.00344	0.0229	CbGeAlD
Ketamine—OPRD1—head—head and neck cancer	0.00306	0.0204	CbGeAlD
Ketamine—OPRK1—head—head and neck cancer	0.00294	0.0195	CbGeAlD
Ketamine—TACR1—lymph node—head and neck cancer	0.00264	0.0176	CbGeAlD
Ketamine—OPRM1—head—head and neck cancer	0.00209	0.0139	CbGeAlD
Ketamine—PTGS1—connective tissue—head and neck cancer	0.00173	0.0115	CbGeAlD
Ketamine—PTGS1—epithelium—head and neck cancer	0.00164	0.0109	CbGeAlD
Ketamine—SLC6A2—head—head and neck cancer	0.00153	0.0102	CbGeAlD
Ketamine—PTGS1—trachea—head and neck cancer	0.00145	0.00966	CbGeAlD
Ketamine—CYP2B6—lymphoid tissue—head and neck cancer	0.0014	0.0093	CbGeAlD
Ketamine—DRD2—head—head and neck cancer	0.00139	0.00927	CbGeAlD
Ketamine—PTGS1—thyroid gland—head and neck cancer	0.00115	0.00764	CbGeAlD
Ketamine—CYP2B6—head—head and neck cancer	0.00113	0.0075	CbGeAlD
Ketamine—SLC6A2—lymph node—head and neck cancer	0.00107	0.00712	CbGeAlD
Ketamine—PTGS1—head—head and neck cancer	0.00102	0.00678	CbGeAlD
Ketamine—ABCB1—epithelium—head and neck cancer	0.000971	0.00646	CbGeAlD
Ketamine—ABCB1—trachea—head and neck cancer	0.000859	0.00571	CbGeAlD
Ketamine—ABCB1—lymphoid tissue—head and neck cancer	0.000748	0.00497	CbGeAlD
Ketamine—PTGS1—lymph node—head and neck cancer	0.000714	0.00475	CbGeAlD
Ketamine—ABCB1—thyroid gland—head and neck cancer	0.000679	0.00452	CbGeAlD
Ketamine—ABCB1—head—head and neck cancer	0.000603	0.00401	CbGeAlD
Ketamine—ABCB1—lymph node—head and neck cancer	0.000422	0.00281	CbGeAlD
Ketamine—CYP2C9—Metabolism—UROD—head and neck cancer	0.000345	0.000696	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—HRAS—head and neck cancer	0.00034	0.000685	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GRP—head and neck cancer	0.00034	0.000685	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—HRAS—head and neck cancer	0.000332	0.000668	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000329	0.000663	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KISS1—head and neck cancer	0.000322	0.000648	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—IL2—head and neck cancer	0.000315	0.000635	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GRP—head and neck cancer	0.000314	0.000632	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—PTEN—head and neck cancer	0.000311	0.000626	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—YAP1—head and neck cancer	0.000307	0.000619	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT6—head and neck cancer	0.000304	0.000613	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—HRAS—head and neck cancer	0.000302	0.000608	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—VEGFA—head and neck cancer	0.000298	0.000601	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—STAT3—head and neck cancer	0.000295	0.000595	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—HRAS—head and neck cancer	0.000294	0.000593	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—VEGFA—head and neck cancer	0.000291	0.000585	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00029	0.000584	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—STAT3—head and neck cancer	0.000288	0.00058	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000287	0.000578	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL2—head and neck cancer	0.000286	0.000577	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MAPK3—head and neck cancer	0.000282	0.000568	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000282	0.000568	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MAPK3—head and neck cancer	0.000275	0.000554	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000273	0.00055	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NAT2—head and neck cancer	0.000273	0.00055	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.00027	0.000545	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000269	0.000543	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—YAP1—head and neck cancer	0.000269	0.000543	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MAPK1—head and neck cancer	0.000268	0.000541	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—head and neck cancer	0.000268	0.00054	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000268	0.00054	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GRP—head and neck cancer	0.000265	0.000534	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MAPK1—head and neck cancer	0.000262	0.000527	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—head and neck cancer	0.000261	0.000527	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000259	0.000522	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT6—head and neck cancer	0.000257	0.000518	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000255	0.000515	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000246	0.000495	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KISS1—head and neck cancer	0.000244	0.000491	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000242	0.000487	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—DPYD—head and neck cancer	0.000239	0.000482	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—MAPK3—head and neck cancer	0.00023	0.000464	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00023	0.000463	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—UROD—head and neck cancer	0.000228	0.000459	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—YAP1—head and neck cancer	0.000228	0.000459	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—YAP1—head and neck cancer	0.000227	0.000457	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—MAPK1—head and neck cancer	0.000219	0.000441	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—head and neck cancer	0.000219	0.000441	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—HRAS—head and neck cancer	0.000215	0.000434	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—head and neck cancer	0.000212	0.000427	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—HRAS—head and neck cancer	0.00021	0.000423	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000209	0.000422	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NAT2—head and neck cancer	0.000208	0.000419	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000208	0.000418	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GRP—head and neck cancer	0.000201	0.000405	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.0002	0.000404	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT6—head and neck cancer	0.000195	0.000393	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—AKT1—head and neck cancer	0.00019	0.000383	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—PIK3CA—head and neck cancer	0.00019	0.000383	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000187	0.000377	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—AKT1—head and neck cancer	0.000185	0.000374	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000185	0.000373	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DPYD—head and neck cancer	0.000183	0.000368	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000181	0.000365	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—head and neck cancer	0.000178	0.000358	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NAT2—head and neck cancer	0.000176	0.000355	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HRAS—head and neck cancer	0.000176	0.000354	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—YAP1—head and neck cancer	0.000173	0.000349	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—YAP1—head and neck cancer	0.000173	0.000348	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000171	0.000345	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AKT1—head and neck cancer	0.000171	0.000345	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000171	0.000344	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—head and neck cancer	0.000169	0.000341	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCND1—head and neck cancer	0.000165	0.000332	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000163	0.000328	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000163	0.000328	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—head and neck cancer	0.000161	0.000325	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PTEN—head and neck cancer	0.000159	0.000321	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—head and neck cancer	0.000156	0.000314	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AKT1—head and neck cancer	0.000155	0.000313	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DPYD—head and neck cancer	0.000155	0.000311	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NAT2—head and neck cancer	0.000154	0.000309	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000152	0.000307	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000151	0.000304	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000149	0.0003	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—YAP1—head and neck cancer	0.000147	0.000295	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—head and neck cancer	0.000144	0.00029	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NAT2—head and neck cancer	0.000143	0.000289	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—STAT3—head and neck cancer	0.000142	0.000287	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—head and neck cancer	0.000141	0.000285	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000141	0.000285	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOTCH1—head and neck cancer	0.000138	0.000279	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000137	0.000276	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TYMS—head and neck cancer	0.000136	0.000275	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK3—head and neck cancer	0.000136	0.000274	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTM1—head and neck cancer	0.000135	0.000271	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DPYD—head and neck cancer	0.000135	0.000271	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—head and neck cancer	0.000132	0.000265	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MAPK3—head and neck cancer	0.00013	0.000261	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK1—head and neck cancer	0.000129	0.000261	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—head and neck cancer	0.000129	0.000261	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GPX1—head and neck cancer	0.000129	0.00026	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—YAP1—head and neck cancer	0.000128	0.000257	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYP1A1—head and neck cancer	0.000128	0.000257	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DPYD—head and neck cancer	0.000126	0.000253	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MAPK1—head and neck cancer	0.000123	0.000249	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—head and neck cancer	0.000123	0.000249	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOTCH1—head and neck cancer	0.000121	0.000245	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—head and neck cancer	0.00012	0.000241	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—YAP1—head and neck cancer	0.000119	0.00024	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000118	0.000238	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000116	0.000233	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK3—head and neck cancer	0.000114	0.000229	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PIK3CA—head and neck cancer	0.000112	0.000226	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00011	0.000222	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—head and neck cancer	0.000109	0.000219	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK1—head and neck cancer	0.000108	0.000218	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—head and neck cancer	0.000108	0.000218	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000107	0.000216	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000105	0.000211	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TYMS—head and neck cancer	0.000104	0.00021	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—head and neck cancer	0.000104	0.000209	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000103	0.000208	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTM1—head and neck cancer	0.000103	0.000207	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOTCH1—head and neck cancer	0.000103	0.000207	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—head and neck cancer	9.98e-05	0.000201	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—head and neck cancer	9.91e-05	0.0002	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GPX1—head and neck cancer	9.84e-05	0.000198	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	9.75e-05	0.000196	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—head and neck cancer	9.63e-05	0.000194	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK3—head and neck cancer	9.61e-05	0.000194	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.61e-05	0.000194	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—head and neck cancer	9.53e-05	0.000192	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NAT2—head and neck cancer	9.46e-05	0.000191	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CA—head and neck cancer	9.39e-05	0.000189	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—head and neck cancer	9.29e-05	0.000187	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—head and neck cancer	9.17e-05	0.000185	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK1—head and neck cancer	9.14e-05	0.000184	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—head and neck cancer	9.14e-05	0.000184	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—head and neck cancer	9.06e-05	0.000183	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.97e-05	0.000181	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTEN—head and neck cancer	8.97e-05	0.000181	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TYMS—head and neck cancer	8.8e-05	0.000177	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—head and neck cancer	8.75e-05	0.000176	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	8.74e-05	0.000176	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTM1—head and neck cancer	8.7e-05	0.000175	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—head and neck cancer	8.69e-05	0.000175	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—head and neck cancer	8.45e-05	0.00017	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—head and neck cancer	8.36e-05	0.000168	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GPX1—head and neck cancer	8.33e-05	0.000168	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DPYD—head and neck cancer	8.29e-05	0.000167	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	8.25e-05	0.000166	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—head and neck cancer	8.15e-05	0.000164	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—head and neck cancer	8.1e-05	0.000163	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—head and neck cancer	8.02e-05	0.000162	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—head and neck cancer	7.93e-05	0.00016	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—YAP1—head and neck cancer	7.87e-05	0.000159	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—head and neck cancer	7.86e-05	0.000158	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.82e-05	0.000158	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	7.78e-05	0.000157	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TYMS—head and neck cancer	7.67e-05	0.000155	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—head and neck cancer	7.67e-05	0.000155	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—head and neck cancer	7.66e-05	0.000154	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—head and neck cancer	7.6e-05	0.000153	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—head and neck cancer	7.58e-05	0.000153	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—head and neck cancer	7.34e-05	0.000148	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK1—head and neck cancer	7.29e-05	0.000147	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—head and neck cancer	7.29e-05	0.000147	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	7.28e-05	0.000147	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPX1—head and neck cancer	7.26e-05	0.000146	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1A1—head and neck cancer	7.19e-05	0.000145	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TYMS—head and neck cancer	7.17e-05	0.000144	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—head and neck cancer	7.14e-05	0.000144	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—head and neck cancer	7.1e-05	0.000143	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—head and neck cancer	7.08e-05	0.000143	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—head and neck cancer	7.06e-05	0.000142	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—head and neck cancer	7.03e-05	0.000142	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	6.93e-05	0.00014	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	6.93e-05	0.00014	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—head and neck cancer	6.88e-05	0.000139	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPX1—head and neck cancer	6.78e-05	0.000137	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.78e-05	0.000137	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—head and neck cancer	6.72e-05	0.000135	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	6.71e-05	0.000135	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—head and neck cancer	6.64e-05	0.000134	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—head and neck cancer	6.62e-05	0.000133	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	6.62e-05	0.000133	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—head and neck cancer	6.48e-05	0.000131	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK1—head and neck cancer	6.39e-05	0.000129	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—head and neck cancer	6.39e-05	0.000129	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—head and neck cancer	6.32e-05	0.000127	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—head and neck cancer	6.12e-05	0.000123	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	6.01e-05	0.000121	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—head and neck cancer	6e-05	0.000121	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—head and neck cancer	5.94e-05	0.00012	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—head and neck cancer	5.85e-05	0.000118	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—head and neck cancer	5.8e-05	0.000117	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—head and neck cancer	5.68e-05	0.000114	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	5.56e-05	0.000112	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—head and neck cancer	5.55e-05	0.000112	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.52e-05	0.000111	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	5.41e-05	0.000109	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK1—head and neck cancer	5.4e-05	0.000109	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—head and neck cancer	5.4e-05	0.000109	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—head and neck cancer	5.37e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—head and neck cancer	5.35e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—head and neck cancer	5.22e-05	0.000105	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—head and neck cancer	5.17e-05	0.000104	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—head and neck cancer	5.13e-05	0.000103	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—head and neck cancer	5.05e-05	0.000102	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—head and neck cancer	5.04e-05	0.000101	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	4.91e-05	9.9e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—head and neck cancer	4.91e-05	9.89e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TYMS—head and neck cancer	4.73e-05	9.52e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—head and neck cancer	4.69e-05	9.44e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—head and neck cancer	4.67e-05	9.42e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.67e-05	9.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	4.55e-05	9.16e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—head and neck cancer	4.53e-05	9.14e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—head and neck cancer	4.53e-05	9.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—head and neck cancer	4.5e-05	9.07e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPX1—head and neck cancer	4.47e-05	9.01e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.43e-05	8.92e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—head and neck cancer	4.34e-05	8.74e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	4.3e-05	8.67e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—head and neck cancer	4.28e-05	8.62e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—head and neck cancer	4.27e-05	8.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	4.09e-05	8.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—head and neck cancer	4.09e-05	8.25e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.99e-05	8.05e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—head and neck cancer	3.83e-05	7.71e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—head and neck cancer	3.82e-05	7.69e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—head and neck cancer	3.73e-05	7.51e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	3.57e-05	7.18e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	3.55e-05	7.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—head and neck cancer	3.48e-05	7.02e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—head and neck cancer	3.44e-05	6.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—head and neck cancer	3.29e-05	6.62e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.02e-05	6.08e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—head and neck cancer	2.91e-05	5.87e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—head and neck cancer	2.9e-05	5.85e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.63e-05	5.31e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.63e-05	5.3e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—head and neck cancer	2.47e-05	4.97e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.46e-05	4.95e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—head and neck cancer	2.3e-05	4.63e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—head and neck cancer	2.15e-05	4.33e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—head and neck cancer	2.01e-05	4.04e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.62e-05	3.26e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.32e-05	2.67e-05	CbGpPWpGaD
